Journal article
Population-based incidence rates and increased risk of EGFR mutated non-small cell lung cancer in Māori and Pacifica in New Zealand
- Abstract:
-
STUDY I: A Combination of Cytokine-Induced Killer Cells With PD-1 Blockade and ALK Inhibitor Showed Substantial Intrinsic Variability Across Non-Small Cell Lung Background: Cancer heterogeneity poses a serious challenge concerning the toxicity and adverse effects of therapeutic inhibitors, especially when it comes to combinatorial therapies that involve more than one targeted inhibitor. In particular, in non-small cell lung cancer (NSCLC), a number of studies have reported synergistic effe...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 772.5KB, Terms of use)
-
- Publisher copy:
- 10.1371/journal.pone.0251357
- Publication website:
- https://bonndoc.ulb.uni-bonn.de/xmlui/bitstream/20.500.11811/11471/2/7563.pdf
Authors
+ University of Auckland
More from this funder
- Funder identifier:
- 10.13039/501100001537
- Grant:
- UoA Doctoral Scholarship
+ Health Research Council of New Zealand
More from this funder
- Funder identifier:
- 10.13039/501100001505
- Grant:
- 13-981, 15-087 and 19-450
- Publisher:
- Public Library of Science
- Journal:
- PLoS ONE More from this journal
- Volume:
- 16
- Issue:
- 5
- Pages:
- e0251357-e0251357
- Publication date:
- 2021-05-07
- DOI:
- EISSN:
-
1932-6203
- ISSN:
-
1932-6203
- Language:
-
English
- Keywords:
- Pubs id:
-
1179136
- Local pid:
-
pubs:1179136
- Source identifiers:
-
W3159018336
- Deposit date:
-
2026-03-24
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2021
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record